• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非经典 CLN2 病的视觉感知和黄斑完整性。

Visual perception and macular integrity in non-classical CLN2 disease.

机构信息

Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3693-3700. doi: 10.1007/s00417-022-05662-1. Epub 2022 Jun 2.

DOI:10.1007/s00417-022-05662-1
PMID:35652945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9581810/
Abstract

PURPOSE

Patients with CLN2 suffer from epileptic seizures, rapid psychomotor decline and vision loss in early childhood. The aim of the study was to provide longitudinal ophthalmic data of patients with confirmed genetic mutation and non-classical disease course, marked by later onset, protracted progression and prolonged life span.

METHODS

Prospective, observational study to assess visual acuity, retinal features (Weil Cornell Ophthalmic Score), central retinal thickness (CRT) measured by optical coherence tomography and general disease progression (Hamburg CLN2 motor language score) in non-classical CLN2 patients.

RESULTS

All patients received intracerebroventricular enzyme replacement therapy with cerliponase alfa. Mean age at last follow-up was 12.4 years; mean follow-up time 2.6 years. All cases demonstrated a stable Hamburg motor language CLN2 Score and Weill Cornell LINCL Ophthalmic Severity Score. Visual function remained stable in 4/6 patients, 2/6 patients showed a decrease, 4/6 cases had a stable CRT and 2/6 showed a reduction of CRT. One patient showed a massive macular thinning and low vision. A correlation with a specific mutation or age could not be verified.

DISCUSSION

The presented longitudinal study characterizes the variable ocular involvement in non-classical CLN2 disease and contributes to the natural history description. The functional and morphologic data outline the necessity of regular ophthalmic examination. Ocular phenotyping and description of retinal degeneration in non-classical CLN2 disease.

摘要

目的

CLN2 患者在幼儿期即出现癫痫发作、精神运动迅速衰退和视力丧失。本研究旨在提供经基因证实的突变和非典型病程患者的纵向眼科数据,这些患者的发病较晚、进展缓慢、寿命延长。

方法

对非典型 CLN2 患者进行前瞻性、观察性研究,以评估视力、视网膜特征(威氏康奈尔眼科评分)、光学相干断层扫描测量的中心视网膜厚度(CRT)以及一般疾病进展(汉堡 CLN2 运动语言评分)。

结果

所有患者均接受了脑室内酶替代疗法用 cerliponase alfa。末次随访时的平均年龄为 12.4 岁;平均随访时间为 2.6 年。所有病例均表现出稳定的汉堡运动语言 CLN2 评分和威氏康奈尔 LINCL 眼科严重程度评分。4/6 例患者的视觉功能保持稳定,2/6 例患者视力下降,4/6 例患者 CRT 稳定,2/6 例患者 CRT 降低。1 例患者出现黄斑大片变薄和低视力。无法证实特定突变或年龄与疾病之间存在相关性。

讨论

本纵向研究对非典型 CLN2 疾病的眼部病变进行了特征描述,有助于对其自然史进行描述。功能和形态数据概述了定期眼科检查的必要性。对非典型 CLN2 疾病的眼部表型和视网膜变性进行描述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc5/9581810/808046e47cee/417_2022_5662_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc5/9581810/cddc02a842d7/417_2022_5662_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc5/9581810/74cd7e967821/417_2022_5662_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc5/9581810/808046e47cee/417_2022_5662_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc5/9581810/cddc02a842d7/417_2022_5662_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc5/9581810/74cd7e967821/417_2022_5662_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bc5/9581810/808046e47cee/417_2022_5662_Fig3_HTML.jpg

相似文献

1
Visual perception and macular integrity in non-classical CLN2 disease.非经典 CLN2 病的视觉感知和黄斑完整性。
Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3693-3700. doi: 10.1007/s00417-022-05662-1. Epub 2022 Jun 2.
2
Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease).尽管采用脑室酶替代疗法用 cerliponase alfa 治疗,但仍持续进行性视网膜变性,见于晚婴儿型神经元蜡样脂褐质沉积症 2 型(CLN2 病)。
Br J Ophthalmol. 2023 Oct;107(10):1478-1483. doi: 10.1136/bjo-2022-321260. Epub 2022 Jun 30.
3
OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy.OCT 生物标志物在接受脑室酶替代治疗的眼部 CLN2 病患者中的作用。
Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):45. doi: 10.1167/iovs.65.8.45.
4
Symmetric Age Association of Retinal Degeneration in Patients with CLN2-Associated Batten Disease.CLN2 相关神经鞘脂沉积症患者视网膜变性的对称年龄相关性。
Ophthalmol Retina. 2020 Jul;4(7):728-736. doi: 10.1016/j.oret.2020.01.011. Epub 2020 Jan 22.
5
An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy.ERG 和 OCT 研究神经元蜡样脂褐质沉积症 CLN2 病 Batten 氏视网膜病变。
Eye (Lond). 2021 Sep;35(9):2438-2448. doi: 10.1038/s41433-021-01594-y. Epub 2021 Jul 16.
6
Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study.晚婴儿型神经元蜡样脂褐质沉积症 2 型(CLN2)患者的疾病特征和进展:一项观察性队列研究。
Lancet Child Adolesc Health. 2018 Aug;2(8):582-590. doi: 10.1016/S2352-4642(18)30179-2. Epub 2018 Jul 2.
7
Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfa.用 cerliponase alfa 对经典晚发性神经元蜡样脂褐质沉积症进行症状前治疗。
Orphanet J Rare Dis. 2021 May 14;16(1):221. doi: 10.1186/s13023-021-01858-6.
8
Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study.Cerliponase alfa 治疗神经元蜡样脂褐质沉积症 2 型(CLN2 病)患儿的安全性和疗效:一项开放标签扩展研究。
Lancet Neurol. 2024 Jan;23(1):60-70. doi: 10.1016/S1474-4422(23)00384-8.
9
Evolution of the retinal function by flash-ERG in one child suffering from neuronal ceroid lipofuscinosis CLN2 treated with cerliponase alpha: case report.神经元蜡样脂褐质沉积症 CLN2 患儿接受 cerliponase alpha 治疗后闪电图 ERG 的视网膜功能演变:病例报告。
Doc Ophthalmol. 2021 Aug;143(1):99-106. doi: 10.1007/s10633-021-09825-z. Epub 2021 May 6.
10
Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis.患有CLN2神经元蜡样脂褐质沉积症的腊肠犬的多灶性视网膜病变。
Exp Eye Res. 2015 May;134:123-32. doi: 10.1016/j.exer.2015.02.012. Epub 2015 Feb 16.

引用本文的文献

1
OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy.OCT 生物标志物在接受脑室酶替代治疗的眼部 CLN2 病患者中的作用。
Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):45. doi: 10.1167/iovs.65.8.45.

本文引用的文献

1
Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world.揭示2型非典型神经元蜡样脂褐质沉积症的临床表型:来自全球最大队列研究的见解
J Paediatr Child Health. 2021 Apr;57(4):519-525. doi: 10.1111/jpc.15250. Epub 2020 Dec 30.
2
Symmetric Age Association of Retinal Degeneration in Patients with CLN2-Associated Batten Disease.CLN2 相关神经鞘脂沉积症患者视网膜变性的对称年龄相关性。
Ophthalmol Retina. 2020 Jul;4(7):728-736. doi: 10.1016/j.oret.2020.01.011. Epub 2020 Jan 22.
3
Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease.
突变更新:TPP1 基因变异与神经元蜡样脂褐质沉积症 CLN2 疾病相关的综述。
Hum Mutat. 2019 Nov;40(11):1924-1938. doi: 10.1002/humu.23860. Epub 2019 Jul 26.
4
Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study.晚婴儿型神经元蜡样脂褐质沉积症 2 型(CLN2)患者的疾病特征和进展:一项观察性队列研究。
Lancet Child Adolesc Health. 2018 Aug;2(8):582-590. doi: 10.1016/S2352-4642(18)30179-2. Epub 2018 Jul 2.
5
Study of Intraventricular Cerliponase Alfa for CLN2 Disease.鞘内注射氯苯唑酸软胶囊治疗 CLN2 病的研究。
N Engl J Med. 2018 May 17;378(20):1898-1907. doi: 10.1056/NEJMoa1712649. Epub 2018 Apr 24.
6
Management Strategies for CLN2 Disease.CLN2病的管理策略
Pediatr Neurol. 2017 Apr;69:102-112. doi: 10.1016/j.pediatrneurol.2017.01.034. Epub 2017 Feb 4.
7
Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs.因TPP1突变导致的迁延性晚发性婴儿蜡样脂褐质沉积症:三例同胞患者的临床、分子及生化特征
J Neurol Sci. 2015 Sep 15;356(1-2):65-71. doi: 10.1016/j.jns.2015.05.021. Epub 2015 May 29.
8
Genetics of the neuronal ceroid lipofuscinoses (Batten disease).神经元蜡样脂褐质沉积症(巴滕病)的遗传学
Biochim Biophys Acta. 2015 Oct;1852(10 Pt B):2237-41. doi: 10.1016/j.bbadis.2015.05.011. Epub 2015 May 27.
9
Spectrum of ocular manifestations in CLN2-associated batten (Jansky-Bielschowsky) disease correlate with advancing age and deteriorating neurological function.CLN2 相关神经鞘脂沉积病(Jansky-Bielschowsky 病)的眼部表现谱与年龄增长和神经功能恶化相关。
PLoS One. 2013 Aug 28;8(8):e73128. doi: 10.1371/journal.pone.0073128. eCollection 2013.
10
Neuronal ceroid lipofuscinoses.神经元蜡样脂褐质沉积症
Handb Clin Neurol. 2013;113:1701-6. doi: 10.1016/B978-0-444-59565-2.00038-1.